Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Net Cash Flow: 2022-2024

Historic Net Cash Flow for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$86.5 million.

  • Lexeo Therapeutics' Net Cash Flow rose 611.58% to $86.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $44.2 million, marking a year-over-year change of. This contributed to the annual value of -$86.5 million for FY2024, which is 295.90% down from last year.
  • Lexeo Therapeutics' Net Cash Flow amounted to -$86.5 million in FY2024, which was down 295.90% from $44.1 million recorded in FY2023.
  • Lexeo Therapeutics' Net Cash Flow's 5-year high stood at $44.1 million during FY2023, with a 5-year trough of -$86.5 million in FY2024.
  • For the 3-year period, Lexeo Therapeutics' Net Cash Flow averaged around -$32.5 million, with its median value being -$55.3 million (2022).
  • As far as peak fluctuations go, Lexeo Therapeutics' Net Cash Flow skyrocketed by 179.84% in 2023, and later tumbled by 295.90% in 2024.
  • Over the past 3 years, Lexeo Therapeutics' Net Cash Flow (Yearly) stood at -$55.3 million in 2022, then soared by 179.84% to $44.1 million in 2023, then slumped by 295.90% to -$86.5 million in 2024.